Interestingly, in some tumors, such as lymphoma, expression of CD70 on tumor cells and APCs improved anti-tumor immunity, whereas, in others, this CD27/CD70 signaling led to decreased anti-tumor immunity and increased Treg populations [195]. The gene discussed is CD27; the disease is lymphoma.